🇺🇸 FDA
Pipeline program

Clifutinib Besylate

HEC73543-AML-102

Phase 2 small_molecule active

Quick answer

Clifutinib Besylate for Acute Myeloid Leukemia, Adult is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Acute Myeloid Leukemia, Adult
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials